Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment ...
As of 10:39:25 AM EST. Market Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback